• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

DWWD:GR

169.2100 EUR 0.8400 0.50%

As of 11:15:59 ET on 11/21/2014.

Snapshot for DWS Biotech (DWWD)

Open: 170.3400 High - Low: 170.8600 - 166.2100 Primary Exchange: Frankfurt
Volume: 302 52-Week Range: 104.8100 - 174.3500 Beta vs NBI: 1.0042

ETF Chart for DWWD

No chart data available.
  • DWWD:GR 170.1500
  • 1D
  • 1M
  • 1Y
168.3700
Interactive DWWD Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for DWWD

DWS Biotech is an open-end fund incorporated in Germany. The Fund's objective is capital growth. The Fund invests primarily in biotech equities worldwide. The Fund focuses on companies in the U.S. and the portfolio may also include selected pharmaceutical and medical equipment firms. The Fund's investment is oriented on the MSCI BioTecnology Select Index.

Inception Date: 1999-08-16 Telephone: Tel. 49-1803-10111011
Managers: NOUSHIN IRANI TURNER / HOLGER GEISSLER
Web Site: www.dws.de

Fundamentals for DWWD

NAV (on 2014-11-21) 169.1700
Assets (M) (on 2014-11-21) 354.9247
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium 0.02
Average 52-Week % Premium -0.7061
Fund Leveraged N

Dividends for DWWD

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2014-10-01) 0.0237
Dividend Yield (ttm) 0.02%

Performance for DWWD

1-Month +10.77% 1-Year +50.43%
3-Month +17.16% 3-Year +49.04%
Year To Date +46.76% 5-Year +32.85%
Expense Ratio 1.70

Top Fund Holdings for DWWD

Filing Date: 08/29/2014
Name Position Value % of Total
Gilead Sciences Inc 386,000 31,506,556 9.894%
Celgene Corp 430,000 30,915,993 9.708%
Biogen Idec Inc 102,317 26,507,727 8.324%
Alexion Pharmaceuticals Inc 138,600 17,710,789 5.562%
Vertex Pharmaceuticals Inc 223,050 15,715,021 4.935%
Illumina Inc 105,000 14,275,823 4.483%
Amgen Inc 125,000 13,161,941 4.133%
Regeneron Pharmaceuticals Inc 47,000 12,379,182 3.887%
BioMarin Pharmaceutical Inc 225,000 11,892,723 3.735%
Salix Pharmaceuticals Ltd 80,000 9,636,564 3.026%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil